HeartBeam Analyst Ratings
HeartBeam Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/24/2023 | 268.66% | Benchmark | → $8 | Reiterates | Speculative Buy → Speculative Buy |
| 05/19/2023 | 155.76% | Alliance Global Partners | $10 → $5.55 | Maintains | Buy |
| 05/19/2023 | 268.66% | Benchmark | → $8 | Reiterates | Speculative Buy → Speculative Buy |
| 03/21/2023 | 268.66% | Benchmark | → $8 | Reiterates | → Speculative Buy |
| 12/02/2022 | 360.83% | Alliance Global Partners | → $10 | Initiates Coverage On | → Buy |
| 12/20/2021 | 314.75% | Benchmark | → $9 | Initiates Coverage On | → Speculative Buy |
| 12/30/2020 | — | Truist Securities | Downgrades | Buy → Hold | |
| 12/18/2020 | 2296.31% | Needham | → $52 | Downgrades | Buy → Hold |
| 09/11/2020 | 2296.31% | Needham | → $52 | Initiates Coverage On | → Buy |
| 09/02/2020 | 1881.57% | Baird | → $43 | Initiates Coverage On | → Neutral |
| 03/19/2020 | 2434.56% | Benchmark | $82 → $55 | Maintains | Buy |
| 02/27/2020 | 3356.22% | Sidoti & Co. | $81 → $75 | Maintains | Buy |
| 01/08/2020 | 2572.81% | SunTrust Robinson Humphrey | → $58 | Initiates Coverage On | → Buy |
| 08/02/2019 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 07/31/2019 | 3909.22% | Sidoti & Co. | $95 → $87 | Maintains | Buy |
| 07/31/2019 | 2388.48% | Raymond James | $62 → $54 | Maintains | Outperform |
| 10/31/2018 | 2849.31% | Raymond James | $66 → $64 | Maintains | Outperform |
| 09/14/2018 | 2941.47% | Raymond James | $57 → $66 | Maintains | Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月24日 | 268.66% | 基準 | →$8 | 重申 | 投機性買入→投機性買入 |
| 2023年05月19日 | 155.76% | 聯盟全球合作夥伴 | $10→$5.55 | 維護 | 買 |
| 2023年05月19日 | 268.66% | 基準 | →$8 | 重申 | 投機性買入→投機性買入 |
| 03/21/2023 | 268.66% | 基準 | →$8 | 重申 | →投機性買入 |
| 12/02/2022 | 360.83% | 聯盟全球合作夥伴 | →$10 | 開始承保 | →購買 |
| 12/20/2021 | 314.75% | 基準 | →$9 | 開始承保 | →投機性買入 |
| 12/30/2020 | - | Truist證券 | 評級下調 | 購買→Hold | |
| 12/18/2020 | 2296.31% | 李約瑟 | →$52 | 評級下調 | 購買→Hold |
| 09/11/2020 | 2296.31% | 李約瑟 | →$52 | 開始承保 | →購買 |
| 09/02/2020 | 1881.57% | 貝爾德 | →$43 | 開始承保 | →中性 |
| 3/19/2020 | 2434.56% | 基準 | $82→$55 | 維護 | 買 |
| 02/27/2020 | 3356.22% | 西多蒂公司 | $81→$75 | 維護 | 買 |
| 1/08/2020 | 2572.81% | SunTrust Robinson Humphrey | →$58 | 開始承保 | →購買 |
| 2019年08月02日 | - | 雷蒙德·詹姆斯 | 評級下調 | 跑贏→市場表現 | |
| 2019年07月31日 | 3909.22% | 西多蒂公司 | $95→$87 | 維護 | 買 |
| 2019年07月31日 | 2388.48% | 雷蒙德·詹姆斯 | $62→$54 | 維護 | 跑贏大盤 |
| 2018年10月31日 | 2849.31% | 雷蒙德·詹姆斯 | $66→$64 | 維護 | 跑贏大盤 |
| 2018年09月14日 | 2941.47% | 雷蒙德·詹姆斯 | $57→$66 | 維護 | 跑贏大盤 |
What is the target price for HeartBeam (BEAT)?
哈特波姆(BEAT)的目標價是多少？
The latest price target for HeartBeam (NASDAQ: BEAT) was reported by Benchmark on August 24, 2023. The analyst firm set a price target for $8.00 expecting BEAT to rise to within 12 months (a possible 268.66% upside). 5 analyst firms have reported ratings in the last year.
Benchmark在2023年8月24日報道了心束(納斯達克：BEAT)的最新目標價。這家分析公司將目標價定為8美元，預計Beats將在12個月內上漲至(可能上漲268.66%)。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for HeartBeam (BEAT)?
分析師對哈特波姆的最新評級是多少？
The latest analyst rating for HeartBeam (NASDAQ: BEAT) was provided by Benchmark, and HeartBeam reiterated their speculative buy rating.
納斯達克(股票代碼：BEAT)的最新分析師評級是由Benchmark提供的，心臟光束重申了他們的投機性買入評級。
When is the next analyst rating going to be posted or updated for HeartBeam (BEAT)?
心束(BEAT)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HeartBeam, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HeartBeam was filed on August 24, 2023 so you should expect the next rating to be made available sometime around August 24, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與HeartBeam的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。紅心光束的上一次評級是在2023年8月24日提交的，所以你應該預計下一次評級將在2024年8月24日左右提供。
Is the Analyst Rating HeartBeam (BEAT) correct?
分析師對哈特波姆(BEAT)的評級正確嗎？
While ratings are subjective and will change, the latest HeartBeam (BEAT) rating was a reiterated with a price target of $0.00 to $8.00. The current price HeartBeam (BEAT) is trading at is $2.17, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的心臟光束(BEAT)評級被重申，目標價在0.00美元至8.00美元之間。哈特波姆(BEAT)目前的交易價格為2.17美元，在分析師的預測範圍內。